Innoviva Inc. (NASDAQ: INVA) is a specialty pharmaceutical company with a diversified portfolio of marketed therapeutics and a growing focus on long-acting drug delivery. The company is reviving the Lyndra Therapeutics long-acting oral drug platform, originally developed at Bob Langer's MIT lab, with Langer and Janet Woodcock as senior advisors.
Company Info
Upcoming Milestones & Key Dates
Lyndra platform revival announcement
Lyndra lead program candidate selection
Potential first Lyndra-program IND filing
Clinical Development Pipeline
Recent News
Innoviva is reviving Lyndra Therapeutics' long-acting oral drug delivery platform with Bob Langer and Janet Woodcock as senior advisors, breathing new life into a once-shelved weekly-pill technology.
Leadership Team
Chief Executive Officer
Chief Operating Officer
Senior Advisor (Lyndra platform)
Careers & Job Openings